Seminars2.20.24

Life Sciences Lifeline: The Bayh-Dole Act, March-In Rights, and the Impact on Innovation

medical research

Late in 2023, the White House released draft guidance outlining proposed factors that an agency may consider, including the “reasonableness of a product’s price,” when deciding whether to exercise its “march-in rights” to federally funded inventions under the Bayh-Dole Act.

Keep Up to Date in a Changing World

Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
Subscription Banner